BOCA RATON, Fla., May 15, 2019 /PRNewswire/ -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the 20th Annual B. Riley FBR Investor
Mr. Sardano's presentation will be webcast live and available for replay in the Investor Relations section of the Company's website at www.sensushealthcare.com.
About Sensus HealthcareSensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions. The Sculptura™ robotic radiation oncology system provides targeted intraoperative triple-modulated radiotherapy (IORT) and Brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, with a single dose. Sensus also offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.
For more information, visit https://www.sensushealthcare.com.
Investor Contact:Kim Sutton GolodetzLHA Investor Relations (212) firstname.lastname@example.org
Media Contacts: Caitlin Kasunich / Brittany TibaldiKCSA Strategic Communications212-896-1241 / email@example.com / firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/sensus-healthcare-to-present-at-the-20th-annual-b-riley-fbr-investor-conference-300850490.html
SOURCE Sensus Healthcare, Inc.
Subscribe to our Free Newsletters!